Loading...

Precipio, Inc.

PRPONASDAQ
Healthcare
Medical - Diagnostics & Research
$14.70
$0.49(3.45%)

Precipio, Inc. (PRPO) Company Profile & Overview

Explore Precipio, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Precipio, Inc. (PRPO) Company Profile & Overview

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOIlan Danieli

Contact Information

203 787 7888
4 Science Park, New Haven, CT, 06511

Company Facts

54 Employees
IPO DateJun 30, 2017
CountryUS
Actively Trading

Frequently Asked Questions

;